Clinical Efficacy of the Combined Effect of Oral Irrigator and Chemicals (0.075% CPC)
NCT ID: NCT06607172
Last Updated: 2024-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
30 participants
INTERVENTIONAL
2024-09-30
2024-10-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group II: waterflosser + dilutable 0.075% CPC
Subjects assigned to this group will use a water flosser device and dilutable chemistry product (0.075% CPC) after dilution each time. Water flosser must be used for one minute. They must use this regimen treatment twice daily (in the morning and evening). No other oral hygiene will be allowed during the 21 days of follow-up.
oral irrigator
water flosser and 0.075% CPC
Cetylpyridinium Chloride (CPC)
Cetylpyridinium 0.075%
Group III: negative control
Subjects assigned to this group will abstain for any oral hygiene during the 21 days of follow-up.
No interventions assigned to this group
Group I: water flosser and water
Subjects assigned to this group will use a water flosser device and water each time. Water flosser must be used for one minute. They must use this regimen treatment twice daily (in the morning and evening). No other oral hygiene will be allowed during the 21 days of follow-up.
oral irrigator
water flosser device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral irrigator
water flosser device
oral irrigator
water flosser and 0.075% CPC
Cetylpyridinium Chloride (CPC)
Cetylpyridinium 0.075%
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 70;
* Available for the three (3) week study duration;
* Good general health for participation in the study, based on the opinion of the study investigator;
* Must have at least 20 natural permanent teeth;
* Teeth must meet the scoring entry criteria for dental plaque and gingivitis (gum inflammation) at the discretion of the study examiner.
Exclusion Criteria
* Presence of fix/ removable prosthodontics dentures that may interfere with this study clinical examinations;
* Advanced periodontal disease (gum disease) and/or treatment for periodontal disease (including surgery) within the past twelve months;
* Five (5) or more decayed, untreated dental sites (cavities) and/or any dental condition requiring urgent dental care;
* Abnormalities/diseases of the soft or hard oral tissues;
* Orthodontic appliances/bands/lingual bars that interfere with any clinical assessment (plaque scoring)
* Use of drugs that can affect salivary flow;
* Use of antibiotics three (3) months prior to study entry and/or during participation in this study;
* Use of any over the counter medications other than analgesics that could interfere with the study at PI discretion;
* Self-reported pregnancy and/or breastfeeding;
* Current Participation in another clinical study or during the month prior to this clinical study entry;
* Known allergies and/or reactions to common dentifrice ingredients;
* Medical condition which prohibits not eating/drinking or chewing gum for four (4) hours prior to your scheduled visits;
* Immunocompromised conditions (AIDS, immunosuppressive drug therapy);
* Infectious disease and/or other blood borne diseases (Hepatitis series, HIV, tuberculosis).
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Pelotas
OTHER
Colgate Palmolive
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wilker Muniz, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of Pelotas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Pelotas
Pelotas, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRO 2024-06-WF-POC-BZ-CB
Identifier Type: -
Identifier Source: org_study_id